Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Revefenacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Revefenacin, including repackagers and relabelers. The FDA regulates Revefenacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Revefenacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Revefenacin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Revefenacin supplier is an individual or a company that provides Revefenacin active pharmaceutical ingredient (API) or Revefenacin finished formulations upon request. The Revefenacin suppliers may include Revefenacin API manufacturers, exporters, distributors and traders.
click here to find a list of Revefenacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Revefenacin DMF (Drug Master File) is a document detailing the whole manufacturing process of Revefenacin active pharmaceutical ingredient (API) in detail. Different forms of Revefenacin DMFs exist exist since differing nations have different regulations, such as Revefenacin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Revefenacin DMF submitted to regulatory agencies in the US is known as a USDMF. Revefenacin USDMF includes data on Revefenacin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Revefenacin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Revefenacin suppliers with USDMF on PharmaCompass.
A Revefenacin written confirmation (Revefenacin WC) is an official document issued by a regulatory agency to a Revefenacin manufacturer, verifying that the manufacturing facility of a Revefenacin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Revefenacin APIs or Revefenacin finished pharmaceutical products to another nation, regulatory agencies frequently require a Revefenacin WC (written confirmation) as part of the regulatory process.
click here to find a list of Revefenacin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Revefenacin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Revefenacin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Revefenacin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Revefenacin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Revefenacin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Revefenacin suppliers with NDC on PharmaCompass.
Revefenacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Revefenacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Revefenacin GMP manufacturer or Revefenacin GMP API supplier for your needs.
A Revefenacin CoA (Certificate of Analysis) is a formal document that attests to Revefenacin's compliance with Revefenacin specifications and serves as a tool for batch-level quality control.
Revefenacin CoA mostly includes findings from lab analyses of a specific batch. For each Revefenacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Revefenacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Revefenacin EP), Revefenacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Revefenacin USP).
LOOKING FOR A SUPPLIER?
